Brian was diagnosed with multiple myeloma in 2015, and since then has experienced a variety of treatments. He credits the work of the MMRF for making those treatments available, and now is enthusiastically joining up with the MMRF and Janssen Oncology for the Vermont to Quebec challenge. Brian heard about the R2V program through patient friend and fellow rider Tim Nash. These two are looking forward to cycling together and supporting one another both on the road and back home in their support group.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More